This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Devanand, D.P. Articles by Levy, S. R. Search for Related Content PubMed PubMed Citation Articles by Devanand, D.P. Articles by Levy, S. R. Social Bookmarking                         What's this?

Neuroleptic Treatment of Agitation and Psychosis in Dementia

Stephanie R. Levy, BA

Neuroleptics remain the mainstay for the treatment of behavioral disturbance and psychotic symptoms in demented patients. The limited available data suggest that low-dose neuroleptics are significantly more efficacious than placebo, though the magnitude of the effect is moderate in most published studies. Demented patients are particularly prone to neuroleptic side effects, and individualized dose titration may be necessary to achieve the optimal trade-off between efficacy and side effects. Target behavioral symptoms and side effects, including effects on cognition and activities of daily life, should be identified and assessed serially during neuroleptic treatment. The choice of neuroleptic depends more on likely side effects than differential efficacy, and non-response or intolerable side effects should lead to dose adjustment or a switch to an alternative class of neuroleptic (or an alternative type of medication). Further studies of optimal neuroleptic dosage, the optimal duration of continuation neuroleptic treatment, and placebo-controlled studies comparing neuroleptics to other classes of medications are needed. (J Geriatr Psychiatry Neurol 1995; 8(suppl 1):S18-S27).

Journal of Geriatric Psychiatry and Neurology, Vol. 8, No. 1, S18-S27 (1995)
DOI: 10.1177/089198879500800104


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J Ellul, N Archer, C M L Foy, M Poppe, H Boothby, H Nicholas, R G Brown, and S Lovestone The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration J. Neurol. Neurosurg. Psychiatry, March 1, 2007; 78(3): 233 - 239. [Abstract] [Full Text] [PDF]

				K Alagiakrishnan, D Lim, A Brahim, A Wong, A Wood, A Senthilselvan, W T Chimich, and L Kagan Sexually inappropriate behaviour in demented elderly people Postgrad. Med. J., July 1, 2005; 81(957): 463 - 466. [Abstract] [Full Text] [PDF]